CBD Companies Will Lose Market Share to Delta 8 THC Hemp Products in 2021
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina,…
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a…
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
WATERTOWN, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage…
ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical…
Nyxol and Low-Dose (0.4%) Pilocarpine Combination to Target Improvement in Near Vision in a Presbyopic…
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Conference call and webcast to be held at 10:00 a.m. ET BOSTON, Feb. 18, 2021…
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or “the…
Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety Lugano, Switzerland,…
Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S. MENLO PARK, Calif.,…
TARGIT Collaborative Group Advocates Wider Adoption of TARGIT-IORT to Address Racial Disparities and Reduce Compliance…
Nes Ziona, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a…
EMERYVILLE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company…
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…